^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    IP-001

    i
    Associations
    News

    Trials

    Company:
    Immunophotonics
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors. (SAKK 66/17) (NCT03993678)
    Phase 1/2
    Swiss Group for Clinical Cancer Research
    Recruiting
    Last update posted :
    02/12/2025
    Initiation :
    10/12/2020
    Primary completion :
    06/30/2025
    Completion :
    12/31/2025
    BRAF
    |
    BRAF mutation
    |
    IP-001